57V-19061-22344
3 vaccinations
2 coded responses
12 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 119 / NY
- Registered
- 2021-04-19
- Relationship
- Self
- Race
- Other
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-04-19
Registered in v-safe
-
2021-04-19
Dose 1 — Pfizer-BioNTech
- 2021-04-21
- 2021-04-22
- 2021-04-29
- 2021-05-05
-
2021-05-10
Dose 2 — Pfizer-BioNTech
- 2021-07-19
- 2021-10-18
-
2022-01-23
Dose 3 — Pfizer-BioNTech
-
2022-01-23
Survey response — day 0, dose 3MedDRA: Pain in extremity — Feeling: Good · Site: Pain · Headache · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
- 2022-02-13
- 2022-02-20
- 2022-03-09
-
2022-04-30
Survey response — 3 months, dose 3MedDRA: Influenza, Oropharyngeal pain — Feeling: GoodMedDRA releases: 2024-11
- 2023-01-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-19 | Pfizer-BioNTech | |
| 2 | 2021-05-10 | Pfizer-BioNTech | No |
| 3 | 2022-01-23 | Pfizer-BioNTech | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Influenza | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SRO | Pain in extremity | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release